Comparison of adaptive seamless Phase 2/3 designs for dose selection in clinical trials with multiple endpoints
Year: 2025
Type: article
Source: Clinical Trials
Author: Man Jin
Institution: AbbVie (United States)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4410743147
